Tag: Sofdra

According to the International Hyperhidrosis Society, approximately 10 million Americans suffer from hyperhidrosis, a condition characterized by excessive sweating. The recent FDA approval of Sofdra (sofpironium) topical gel offers a new treatment option for this often-debilitating condition, prompting many to ask: Has anyone tried Sofdra yet? Initial patient reviews are overwhelmingly positive, with many reporting significant relief and fewer side effects compared to other treatments.

Excessive sweating, or hyperhidrosis, affects an estimated 10 million people in the U.S., significantly impacting their quality of life. A new drug for excessive sweating, Sofdra (sofpironium bromide) topical gel, was approved by the U.S. Food and Drug Administration (FDA) in June 2024, marking a significant advancement in treating primary axillary hyperhidrosis (excessive underarm sweating). This prescription medication offers a new, patient-applied, at-home option for adults and children as young as nine.